SPHK2 and glioblastoma: Indeed, our findings demonstrate an interplay between the downregulation of IC1 in GBM and an increase in SK2 plasma membrane localization, which was decreased by re-expression of IC1, resulting in reduced GBM tumor growth in vivo.